Structure−Activity Study of Brassinin Derivatives as Indoleamine 2,3-Dioxygenase Inhibitors
Year: 2005
Type: article
Abstract: A screen of indole-based structures revealed the natural product brassinin to be a moderate inhibitor of indoleamine 2,3-dioxygenase (IDO), a new cancer immunosuppression target. A structure-activity study was undertaken to determine which elements of the brassinin structure could be modified to enhance potency. Three important discoveries have been made, which will impact future IDO inhibitor development: (i) The dithiocarbamate portion of the brassinin lead is a crucial moiety, which may be binding to the heme iron of IDO; (ii) an indole ring is not necessary for IDO inhibition; and (iii) substitution of the S-methyl group of brassinin with large aromatic groups provides inhibitors that are three times more potent in vitro than the most commonly used IDO inhibitor, 1-methyl-tryptophan.
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm0508888
Authors: Paul Gaspari, Tinku Banerjee, William P. Malachowski, Alexander J. Muller, George C. Prendergast, James DuHadaway, Shauna Bennett, Ashley M. Donovan
Institutions: Bryn Mawr College, Lankenau Institute for Medical Research
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W1997582687
